 2
 
英文摘要 
Ion pair amphiphiles (IPAs), obtained by mixing aqueous solutions of anionic and 
cationic surfactants, were used by a proper process to prepare catanionic vesicles with 
reasonable stability and specific charge characteristics.  The particle size distribution and 
zeta potential measurements indicated that by adding the single-chain anionic or cationic 
surfactants, the components of the IPA, in the aqueous phase during the hydration of the IPA 
film in the process, one was able to obtain charged catanionic vesicles.  However, the vesicle 
stability could not be solely explained by the zeta potential data.  For the positively charged 
catanionic vesicles prepared from the mixture of IPA HTMA-DS (was obtained from the 
anionic surfactant, sodium dodecylsulfate (SDS), and the cationic surfactant, 
hexadecyltrimethylammonium bromide (HTMAB)) with HTMAB, the particle size analysis 
demonstrated that with the addition of a proper amount of n-hexadecanol or n-octadecanol in 
low concentration HTMA-DS/HTMAB systems, the physical stability of catanionic vesicles 
could be enhanced, especially for the presence of n-octadecanol. When n-hexadecanol or low 
molar ratios of n-octadecanol were present in high concentration HTMA-DS/HTMAB 
systems, the vesicle stability would become lower. By adding a proper amount of 
n-octadecanol, more stable vesicle dispersions could then be prepared. However, the effects of 
n-hexadecanol or n-octadecanol on promoting the vesicle stability were less significant than 
that of cholesterol, suggesting that the composition and packing of the vesicle bilayers had 
strong influence on the vesicle stability.  Moreover, the zeta potential analysis indicated that 
the positively charged catanionic vesicles with reasonable stability were able to associate with 
DNA to form stable vesicle/DNA complexes and had the potential as DNA delivery carriers. 
 
keywords：catanionic surfactant, catanionic vesicle, DNA delivery carrier, ion pair amphiphile, 
vesicle  
 
 4
性，並藉由粒徑分布和界面電位的量測，探討陰陽離子液胞與 DNA 的結合行為。 
 
 
實驗 
十二烷基硫酸鈉（ sodium dodecylsulfate, SDS ）、十二烷基三甲基溴化銨
（ dodecyltrimethylammonium bromide, DTMAB ）、 十 四 烷 基 三 甲 基 溴 化 銨
（ tetradecyltrimethylammonium bromide, TTMAB ）、 十 六 烷 基 三 甲 基 溴 化 銨
（hexadecyltrimethylammonium bromide, HTMAB）、、正十六碳醇、正十八碳醇及膽固
醇，均購自 Sigma 公司，USA，純度為 99％。所有的藥品在使用前皆未經進一步的純
化。氯仿（HPLC 級）購自美國 Mallinckrodt Baker Inc.。實驗使用的純水皆經過 Milli-Q 
plus 純水機（Millipore，USA）的純化，純化後純水的初始比阻抗值為 18.2 MΩ-cm。 
當以等比例將高濃度的陰離子型與陽離子型界面活性劑水溶液混合時，可形成離子
對雙親分子（ion pair amphiphile, IPA）的固狀沈澱。製備 IPA（DTMA-DS、TTMA-DS
及 HTMA-DS）時，先分別配製濃度為 20 mM 的陰離子型與陽離子型界面活性劑水溶
液，將兩者均勻混合攪拌一天。再藉由反覆的離心、水洗以分離出固狀沈澱物，並經乾
燥與研磨成粉狀後，供製備陰陽離子液胞時使用（Chien et al., 2002）。 
進行陰陽離子液胞（catanionic vesicle）的製備時，先取適量的 IPA 及添加劑置於圓
底燒瓶中，加入 10 ml 氯仿，待 IPA 完全溶解後再放入直徑 3mm 的玻璃珠至液高，並
通入高純度氮氣使氯仿完全揮發。隨後再加入含有與 IPA 組成分子相同的單鏈陰離子型
或陽離子型界面活性劑溶液進行水合，溶液量皆固定為 60 ml。在水合過程中，則利用
超音波震盪分散裝置（model VC750, Sonics & Materials, Inc., USA），在恆溫 60 ℃下以
60 W 功率對溶液進行震盪分散 60 分鐘，使 IPA 薄膜得以完全水合並形成液胞。隨後將
製得的液胞分散液置入微脂粒擠壓器（Lipex Biomembrane, Canada）中，並在壓力 250 
psi，溫度 60℃的條件下依序通過孔徑大小為 0.4 及 0.2 μm 的 polycarbonate 濾膜
（Osmonics，USA），以獲得較均一之粒徑分布的液胞分散液。 
所生成液胞的粒徑分布及界面電位，則利用英國 Malvern 公司的的粒徑與界面電位
量測儀（model Zetasizer 3000HS 或 Nano ZS）進行量測，儀器使用的是波長 632.8 nm 的
10 mW 氦氖雷射光源，所有的量測均於恆溫 25 ℃下進行。進行穿透式電子顯微鏡分析
時，則先取適量液胞分散液滴於附有支撐膜（formvar film）的鍍碳銅網（200 mesh, Pelco, 
USA）上，然後等待一段時間讓液胞嵌在銅網上。接著用濾紙吸去多餘的溶液，再滴上
 6
與探討。在不同 XDS組成下，剛製備形成的陰陽離子液胞分散液的粒徑分布，如圖 3 所
示。在初始的粒徑分布方面並沒有顯著的差異，平均粒徑約 100 nm，此結果可以確定這
些組成都能生成液胞，也顯示液胞的粒徑分布並不會因組成改變而明顯受到影響。此
外，由各組成之界面電位分析結果可以發現其值皆為+64 mV 左右，組成不同但界電電
位卻相似，可能是因為液胞粒徑大小接近，液胞表面所能負荷的電子密度相近，少量的
界面活性劑分子即可使液胞的表面達到相當程度的電位，多餘的界面活性劑分子則仍存
在水相環境中。 
若以分散液中出現粒徑超過 3 μm 所需的時間做為物理穩定性的依據，則當 XDS = 
0.45、0.4、0.35、0.3 與 0.2 時，其物理穩定的天數則分別為 1、77、44、14 與 8 天。可
見隨著組成中陽離子型界面活劑的量相對增加時，所形成之液胞的界面電位變化並不
大，但穩定性卻逐漸下降，此結果同樣顯示液胞所帶電性並不能完全解釋液胞物理穩定
性的結果。此外，也發現僅需添加些微的界面活性劑，即能使液胞具有最適當的穩定性
與界面電位，而添加之界面活性劑分子的量增加時，不僅不能提升液胞的電性，反而降
低其物理穩定性。 
 
添加劑促進陰陽離子液胞穩定性的效果 
為進一步了解液胞的雙層膜組成對於提升陰陽離子液胞穩定性的影響，嘗試先在
IPA 中加入膽固醇以形成混合薄膜，再與含有單鏈界面活性劑的水溶液進行水合，以形
成含有膽固醇的陰陽離子液胞分散系統。以 HTMA-DS 系統為例，在以 4 mM HTMA-DS
與 2 mM HTMAB 組成的帶正電陰陽離子液胞系統中，若於製膜過程添加 3 mM 的膽固
醇，則在經過 90 天後，液胞的粒徑分布並無明顯增大的現象，可見適量的膽固醇確有
促進陰陽離子液胞穩定性的效果（圖 4）。此一結果也說明在液胞雙層膜結構中分子彼此
之間的作用力，在液胞的物理穩定性上扮演重要的角色。此外，含有 30 mol %膽固醇的
液胞，界面電位的量測卻顯示液胞界面電位變得較零亂，其中一組實驗結果為 55 mV，
另一組則為 24 與 148 mV，但在靜置 7 天與 30 天後，界面電位的量測結果幾乎與未添
加膽固醇時的結果相同。這結果說明剛製備完成時的陰陽離子液胞，尚未達到穩定狀
態，但經過一段時間靜置後，液胞的界面電位仍會與未添加膽固醇時的結果類似。 
於 HTMA-DS/HTMAB = 0.2 mM/0.6 mM 混合系統中，添加不同濃度的添加劑正十
六碳醇或正十八碳醇，剛製備完成時的液胞粒徑分布如圖 5 所示。分散液的初始粒徑分
布皆在 50～400 nm 的範圍內，顯示分散液內有液胞存在。將液胞分散液長時間靜置並
 8
由 HTMA-DS/HTMAB = 4 mM/2 mM 混合系統形成的液胞，物理穩定天數可達 32 ± 
2 天。由 TEM 直接觀察液胞的形態，顯示粒徑分布在 60～170 nm，由粒徑大小可合理
推測這些粒子為液胞（圖 6）。因液胞在分散液中運動時可能會挾帶一層緊密結合的水分
子，使得由粒徑分析儀測得的結果較 TEM 的分析結果稍大。在此混合系統中添加不同
濃度的正十六碳醇或正十八碳醇，液胞分散液在剛製備完成時外觀皆呈淡藍色，粒徑分
布則如圖 7 所示，皆比未添加時的小，且大多出現 10～30 nm 的小粒徑分布訊號。液胞
的界面電位與物理穩定性則如表 2 所示。添加正十六碳醇或 1、2 mM 的正十八碳醇，
形成的液胞仍具有穩定的正電位，但物理穩定性卻較差，此結果應與液胞雙層膜的組成
及結構有關。 
    由粒徑及界面電位的分析結果，推測在混合系統中添加 1、3 或 5 mM 的正十六碳
醇，或者是 1 或 2 mM 的正十八碳醇，在液胞製程之製膜步驟中形成的薄膜都可能有相
分離出現，使得分子的排列不均而產生缺陷。即液胞的雙層膜結構中有空隙出現，使液
胞容易發生融合/聚集現象，導致其物理穩定性不佳。而在混合系統中添加 3～5 mM 的
正十八碳醇，由界面電位分析出現單一訊號的結果推測，液胞雙層膜內的相分離程度較
小，且正十八碳醇加強了膜內分子間的凡得瓦爾作用力，因此可進一步提升液胞的物理
穩定性。不過添加正十六碳醇或正十八碳醇促進液胞物理穩定性的效果，似乎都比不上
添加膽固醇的效果顯著（表 2）。 
 
稀釋效應對帶電陰陽離子穩定性的影響 
當在單鏈界面活性劑總濃度為 10 mM 的 HTMA-DS/HTMAB (XDS=0.4)系統中添加
30 mol%膽固醇時，剛製備完成之液胞分散液中的液胞粒徑分布為 10～200 nm，穩定性
可達 80 天以上（表 3）。若由 10 mM 原液稀釋為 2 mM、1.5mM、1mM、0.75mM 及 0.5mM
的液胞分散液時，其液胞粒徑分布也都為 10～200 nm 或 20～200 nm，且穩定性至少達
10 天以上。TEM 的分析結果也與粒徑分析儀的量測結果吻合（圖 8）。若由 10 mM 原液
直接稀釋為 0.1 mM 的液胞分散液，起始的粒徑分布雖仍為 10～200 nm，但是在第 7
天就產生粒子聚集的不穩定現象。此外，由粒徑分布的分析結果發現，膽固醇的添加的
確有達到促進液胞穩定性的效果。 
 
陰陽離子液胞與 DNA 的結合行為 
當單鏈界面活性劑總濃度為 10mM 的 HTMA-DS/HTMAB（XDS=0.4）液胞分散液與
 10
液胞物理穩定性的效果比正十六碳醇明顯。 
為進一步增加液胞結構的穩定，本研究也嘗試在可形成帶正電液胞的系統中添加
適當比率的膽固醇，結果顯示膽固醇的添加確實能使液胞粒徑增加的趨勢變緩，且效果
比正十六碳醇及正十八碳醇佳。雖然在剛製備完成時，添加膽固醇所形成液胞的界面電
位與未添加膽固醇時略有不同，但經過一段時間後，二者的界面電位並不明顯的差異。
此外，所製備的帶正電陰陽離子液胞分散液經稀釋後仍有適當的穩定性，可供後續之應
用，並可與帶負電的 DNA 結合形成穩定的複合物，值得進一步評估做為 DNA 傳輸載
體的可行性。 
 
 12
 
 
表 1  添加劑對 HTMA-DS/HTMAB = 0.2 mM/0.6 mM 混合系統所形成之液胞分散液
界面電位及物理穩定性的影響。 
 
添加劑及濃度 
（mM） 
平均界面電位
（mV） 
液胞可穩定的時間
（day） 
 
無                         -41, 74               6 ± 1 
膽固醇 
 0.3                     49, 67, 87              > 99 
正十六碳醇   
0.1 -48, 57, 87 13 ± 2 
0.2 -40, 71, 102 17 ± 2 
0.3                     -102, 71, 107           13 ± 1 
0.4 -104, 84 14 ± 1 
0.5 -34, 73 12 ± 1 
正十八碳醇   
0.1 -10, 119 13 ± 1 
0.2 -43, 90 47 ± 3 
0.3                      -23, 103              42 ± 2 
0.4 75 41 ± 1 
0.5 74 23 ± 2 
   
 
 14
 
 
表 3 含有 30 mol%膽固醇之 HTMA-DS/HTMAB (XDS=0.4)系統形成之陰陽離子液胞分
散液，於不同稀釋情況下的粒徑分布及物理穩定性。 
 
液胞濃度 
（mM） 
液胞分散液的 
粒徑分布  
(nm) 
液胞可穩定的時間
（day） 
10 10～200 > 80 
2 10～200 > 10 
1.5 20～200 > 10 
1 20～200 > 10 
0.75 20～200 > 10 
0.5 20～200 > 10 
0.1 10～200 7 
 
 
 
 
 
 
 
 
 
 16
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
圖 2 3 mM DTMA-DS（C12-C12）與 4 mM SDS 混合形成之液胞分散液的物理穩定性（上
左圖）及帶電特性（上右圖），以及 4 mM HTMA-DS（C16-C12）與 2 mM HTMAB
混合形成之液胞分散液的物理穩定性（下左圖）及帶電特性（下右圖）。 
 
 18
 
 
 
 
 
 
 
 
 
 
圖 4 在 HTMA-DS 與 HTMAB 的混合系統中，當 XDS = 0.4 時，（a）未添加與（b）添
加 30 mol %的膽固醇所形成的液胞分散液，其平均粒徑隨時間的變化。 
 
 20
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
圖 6   HTMA-DS/HTMAB = 4 mM/2 mM 混合系統形成之液胞的（上）8 萬倍及（下）
30 萬倍 TEM 分析圖。 
 
 
100nm 
100nm 
 22
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
圖 8 在單鏈界面活性劑總濃度為 10 mM 的 HTMA-DS/HTMAB（XDS=0.4）系統中，
添加 30 mol%膽固醇所形成之液胞分散液，經稀釋成 1.5 mM 後的液胞 TEM 分析
圖。 
50 nm 
20 nm 
 24
 
計畫成果自評 
此三年研究計畫的工作內容，第一年度是先針對強制性製程的條件進行調控，以開
發可更精確控制帶電陰陽離子液胞之生成的強制性製備程序。在第二年度則探討液胞的
組成對其物理穩定性的影響，並評估以添加劑促進陰陽離子液胞之物理穩定性的效果。
第三年度則針對液胞分散液經稀釋後的物理穩定性，以及液胞/DNA 之結合行為進行分
析。目前的執行成果已達成所規劃的預期目標。 
在此研究中，已成功建立利用液胞組成材料 IPA 薄膜的形成及水合，強制生成帶電
且具適當粒徑穩定性之陰陽離子液胞分散液的製程。透過此強制性製備液胞的程序，除
了可製備出高濃度且具適當穩定性的陰陽離子液胞外，利用離子型界面活性劑及添加劑
的調控，可進一步掌控陰陽離子液胞的物理穩定性及帶電特性，以製備具適當大小及特
殊電性的液胞。例如以 HTMA-DS/HTMAB/正十八碳醇為材料所形成液胞之粒徑穩定性
可達 50 天，界面電位超過 50mV。所製備之帶正電陰陽離子液胞亦證實可與 DNA 結合，
並形成具適當穩定性的陰陽離子液胞/DNA 複合物。此一研究成果可彌補先前自發性形
成液胞所普遍遇到的液胞濃度不高與相態複雜的問題，且可進一步控制液胞表面的帶電
行為，並應用於後續 DNA 傳輸載體的開發。 
 
 2
的研究心得外，也針對未來可能合作的研究主題及方式做進一步的溝通。 
在 reception 活動中，除了與熟識的學者敘舊及討論研究近況外，也在交談中認
識了幾位研究學者，包括泰國 Chulalonghorn 大學 S. Chavadej、中國北京大學 J. Zhang
等教授，並就雙方的研究主題與內容做初步的了解。此外，這次會議 plenary lectures
之一的 Eric W. Kaler 教授，在十多年前聆聽過他的演講後即未再碰面。此次在經過多
年後再次相遇，除了就研究主題及內容進行討論外，也邀請他下次至亞洲開會時能順
道至台灣訪問並至成大進行學術演講。 
10 月 28 日，研討會在經過簡單的開幕儀式後，隨即進行三天的緊湊會議。整個
會議包含了自組裝材料、分散系統、界面、薄膜、分析方法及理論、工業及生醫應用
等主題，主辦單位共邀請了 4 位學者進行 plenary lecture，27 位學者進行 invited 
lecture。此外，尚有 12 篇 oral presentation 及 106 篇壁報論文的發表。由於是在中國
舉辦會議，因此參加會議的以中國的學者及研究人員為主，進行 plenary lecture 的 4
位學者，則分別來自美國、德國、日本及中國，而受邀演講者除了中國學者外，則來
自亞洲多個國家，包括蘇俄、韓國、日本、台灣、泰國、印度、巴基斯坦等。 
本人在此次會議中，受邀進行一場 invited lecture，內容是執行前一個國科會三年
研 究 計 畫 的 成 果 ， 講 題 為 「 Dynamic monolayer behavior of dipalmitoyl 
phosphatidylcholine with albumin at the air/liquid interfaces」（在氣 /液界面上之
dipalmitoyl phosphatidylcholine/albumin 的動態單分子層行為）。在此研究中，利用
Langmuir 槽系統並配合反射-吸收式紅外光譜分析技術，探討於動態壓縮-擴張氣/液
界面面積的情況下，血漿蛋白質 albumin 對氣 /液界面上之磷脂質 dipalmitoyl 
phosphatidylcholine （DPPC）單分子層行為的影響。結果顯示當氣 /液界面上的
DPPC/albumin 混合分子層處於壓縮狀態時，被排擠出界面的 albumin 分子會同時帶
走界面上部分具界面活性的 DPPC 分子。而當氣/液界面擴張時，albumin 分子比 DPPC
分子能更迅速地再吸附到界面上，佔據部分界面面積，因而對肺泡界面活性劑中
DPPC 分子的動態界面活性產生抑制效應。此一研究成果，有助於了解血漿蛋白質對
DPPC 界面活性的抑制機制，並可進一步說明血漿蛋白質在成人呼吸窘迫症候群形成
 4
方已有初步的合作研究成果。利用此次參與會議的機會，我們得以進一步面對面地討
論後續之合作研究及論文發表事宜，可算參加此一會議的額外收穫。 
 
 
三、建議 
 
參加國際研討會是與各國研究學者交流的重要途徑，透過面對面的討論及溝通，
也較易建立未來的合作關係，因此值得鼓勵學者及學生出國參與研討會。只是受到計
畫經費的限制，一般的國科會研究計畫實難支持學生出國參與研討會。目前雖有管道
可供學生申請出國開會的經費補助，但普遍性仍不足。相關單位或可考慮採取一些措
施，增加學生申請出國開會之經費補助的管道。 
 
 
四、攜回資料名稱及內容 
 
「The 2nd Asian Conference of Colloid and Interface Sciences」會議論文摘要集，
內含 4 篇 plenary lecture、27 篇 invited lecture、12 篇口頭報告及 106 篇壁報展示的論
文摘要。 
 
 6
Abstract  
 
This study investigated the influence of albumin on the dipalmitoyl phosphatidylcholine 
(DPPC) monolayer behavior at cyclic air/liquid interfaces by the infrared reflection-absorption 
spectroscopy. When DPPC molecules were spread at the interface of air/1000 ppm albumin solution, 
the induced close packing of DPPC molecules at the interface by the preadsorbed albumin 
molecules was demonstrated by the higher absolute νa-CH2 (the antisymmetric methylene stretching 
vibration) reflectance-absorbance (RA) value and the lower νa-CH2 wavenumber in comparison 
with that of a pure DPPC monolayer. Under the continuous interface compression-expansion 
condition, at the end of the compression stage, the absolute νa-CH2 RA value of the mixed 
DPPC/albumin layer was lower than that of a pure DPPC monolayer, which implied that extra 
DPPC molecules were removed from the interface upon interface compression in the presence of 
albumin. Similar behavior has been found for the mixed DPPC/fibrinogen system. Moreover, during 
the compression stage, the absolute amide I (C=O stretching mode) RA value always decreased, 
indicating the significant expulsion of albumin from the interface. During the following interface 
expansion stage, the absolute νa-CH2 RA value decreased gradually to a value close to that of a pure 
DPPC monolayer. However, it could be expected that a smaller number of free DPPC molecules 
were present at the interface if one took account of the albumin adsorption, which was implied by 
the increased absolute amide I RA value upon interface expansion. In addition, the νa-CH2 
wavenumber was essentially unchanged during the interface expansion stage, suggesting that the 
free DPPC molecules at the interface were always in a highly ordered state. The close packing of 
DPPC molecules upon interface expansion apparently resulted from the significant adsorption of 
albumin molecules. 
 
Keywords: air/liquid interface, lipid/protein monolayer, lung surfactant, mixed monolayer, 
monolayer 
 8
There is no doubt that general principles involved in the inhibitory effect of plasma proteins on 
the dynamic surface activity of DPPC or lung surfactant systems can be derived from past reports. 
Nevertheless, recent mixed monolayer studies especially with sophisticated experimental designs 
and/or in situ microscopic/spectroscopic techniques do provide more detailed information about the 
interactions of plasma proteins with phospholipids at interfaces. Thus this study will focus on the 
recent progress in understanding the dynamic interfacial properties of mixed DPPC/albumin 
monolayers at air/liquid interfaces. 
 
Experimental 
Monolayer behavior analysis 
To study mixed phospholipid/protein monolayer behavior at air/liquid interfaces, a widely 
applied method is to use the Langmuir film balance to record changes of surface pressure as a 
function of the molecular area at constant temperature or the surface pressure-area (π-A) isotherm. 
The surface pressure (π) is defined as the surface tension difference of pure subphase (γo) with the 
subphase containing a monolayer (γ) and can be calculated from the relationship π = γo - γ. In a 
Langmuir film balance, an aqueous subphase is contained in a so-called Langmuir trough with one 
or two movable barriers. An organic solvent sample containing monolayer-forming materials can be 
spread at the air/liquid interface usually by a microsyringe. A period of 10-20 min is allowed for 
solvent evaporation, and the spread monolayer is then formed at the interface. Compression or 
expansion of the monolayer at the interface can be carried out with the computer-controlled 
movable barriers, and the corresponding surface pressure variations are usually measured with the 
Wilhelmy plate method. A surface pressure-area (π-A) isotherm can thus be constructed. When an 
interface compression-expansion process is applied, the π-A hysteresis isotherm can be recorded. 
This allows one to study the mechanisms of monolayer respreading and/or dynamic adsorption 
behavior of molecules at the interface during cyclic area changes [9,10].  
 
 10
 
Results and discussion 
The interface compression-expansion hysteresis curves of a mixed spread DPPC/adsorbed 
albumin layer on a 1000 ppm albumin subphase are demonstrated in Fig. 1. During the first 
compression stage, a prominent plateau at the surface pressure ~ 58 mN/m was detected. It has been 
proposed that, at lower surface pressures, where the pure lipid was expanded, homogeneous 
lipid-protein monolayers might be obtained. However, the monolayers could then demix at higher 
surface pressures, where the pure lipid was condensed [18,19]. Therefore, the observed surface 
pressure transition in the compression curve of a mixed DPPC/albumin monolayer could be 
explained by the extensive exclusion of albumin molecules from the mixed monolayer due to the 
close packing of insoluble DPPC molecules. A similar plateau has been observed in the 
compression curve of a mixed DPPC/surfactant protein-C (SP-C) layer at the air/liquid interface, 
and it was suggested that material was removed upon compression but remained to associate with 
the monolayer [20].     
Upon further compression, a characteristic collapse plateau of a DPPC monolayer was 
observed in the compression isotherm (Fig. 1). Thus, most of the albumin molecules seemed to be 
preferentially expelled from the monolayer, resulting in a condensed phase mainly consisting of 
DPPC with a collapse plateau similar to that of a pure DPPC monolayer. Similar behavior has been 
found for mixed DPPC/β-lactoglobulin monolayers by synchrotron X-ray experiments at grazing 
incidence [21].  
During the interface expansion stage, the surface pressure of the mixed monolayer decreased 
sharply and then increased gradually until the end of the expansion stage, which suggested the 
re-entry of surface-active materials (mostly albumin) at the interface, especially at larger interface 
areas (Fig. 1). Keough et al. [7] have also found that proteins might compete with surfactants for 
surface space under conditions when the layers were not highly compressed. The formation of a 
protein-dominated layer at the interface may prevent the phospholipid adsorption [8]. In addition, 
 12
poor respreading ability, the close packing of free DPPC molecules was apparently related to the 
significant adsorption of albumin molecules to the interface upon interface expansion. Under the 
circumstances, more albumin molecules were available at the interface and occupied part of the 
space at the interface, enhancing the conformational order of the hydrocarbon chains of the 
remaining free DPPC molecules. 
During the second and third interface compression-expansion cycles, the decreased absolute 
νa-CH2 RA values detected at the ends of the cycles suggested that some of the remaining free 
DPPC molecules after the first cycle were further removed with albumin during the cycles (Fig. 3a). 
The intensity changes might seem insignificant, but the variations in the surface concentration of 
free DPPC molecules would be pronounced, if one considered the albumin molecules adsorbed at 
the interface and occupied certain interface space upon interface expansion. The significant albumin 
adsorption during the interface expansion stage can be realized from the absolute amide I RA values 
detected at the end of each cycle (Fig. 4). 
 
Conclusion 
Evidence from this study supports that the inhibition of DPPC dynamic surface activity at the 
cyclic interface by albumin may be explained by the partly exclusion of albumin associated with the 
removal of DPPC at the interface during interface compression and by the significant re-entry of 
albumin during the subsequent interface expansion. In a continuous interface 
compression-expansion process, the induced loss of free DPPC molecules by albumin expulsion 
from the interface and the dominant readsorption of albumin molecules to the interface will result in 
pronounced depletion and thus an incomplete monolayer of DPPC at the interface. However, the 
roles of albumin structures in the protein-induced DPPC removal still remain to be studied. The 
abilities of in situ IRRAS technique to probe the mixed phospholipid/plasma protein monolayer 
composition and possibly to perform the conformational analysis of protein secondary structures 
may offer a means to resolve this issue.  
 14
References 
 
[1] Boucher, J., E. Trudel, M. Méthot, P. Desmeules & C. Salesse (2007) Organization, structure 
and activity of proteins in monolayers, Colloids Surf. B: Biointerfaces, 58: 73-90. 
[2] Goerke, J. (1998) Pulmonary surfactant: functions and molecular composition, Biochim. 
Biophys. Acta, 1408: 79-89. 
[3] Notter, R.H. (1989) Physical chemistry and physiological activity of pulmonary surfactants, in: 
Surfactant Replacement Therapy (Shapiro, D.L. & R.H. Notter eds.), A. R. Liss, New York, pp. 
19-70. 
[4] Keough, K.M.W. (1992) Physical chemistry of pulmonary surfactant in the terminal spaces, in: 
Pulmonary Surfactant: From Molecular Biology to Clinical Practice (Robertson, R., L.M.G. 
van Golde & J.J. Batenburg eds.), Elsevier, Amsterdam, pp. 109-164. 
[5] Ikegami, M., A. Jobe, H. Jacobs & R. Lam (1984) A protein from airways of premature lambs 
that inhibits surfactant function, J. Appl. Physiol., 57: 1134-1142. 
[6] Gunther, A. & W. Seeger (1995) Resistance to surfactant inactivation, in: Surfactant Therapy 
for Lung Disease (Robertson, B. & H.W. Taeusch eds.), Marcel Dekker, New York, pp. 
269-292. 
[7] Keough, K.M.W., C.S. Parson, P.T. Phang & M.G. Tweeddale (1988) Interactions between 
plasma proteins and pulmonary surfactant: surface balance studies, Can. J. Physiol. 
Pharmacol., 66: 1166-1173. 
[8] Holm, B.A., G. Enhorning & R.H. Notter (1988) A biophysical mechanism by which plasma 
protein inhibits surfactant activity, Chem. Phys. Lipids, 49: 49-55. 
[9] Chang, C.-H., S.-D. Yu, T.-K. Chuang & C.-N. Liang (2000) Roles of 　-globulin in the 
dynamic interfacial behavior of mixed dipalmitoyl phosphatidylcholine/　-globulin 
monolayers at air/liquid interfaces, J. Colloid Interface Sci., 22: 461-468.  
[10] Kuo, R.-R., C.-H. Chang, Y.-M. Yang & J.-R. Maa (2003) Induced removal of dipalmitoyl 
 16
[21] Zhao, J., D. Vollhardt, G. Brezesinski, S. Siegel, J. Wu, J.B. Li & R. Miller (2000) Effect of 
protein penetration into phospholipid monolayers: morphology and structure, Colloids Surf. A: 
Physicochem. Eng. Aspects, 171: 175-184. 
[22] Gericke, A. & H. Hühnerfuss (1993) In situ investigation of saturated long-chain fatty acids at 
the air/water interface by external infrared reflection-absorption spectrometry, J. Phys. Chem., 
97: 12899-12908. 
 
 
 
 18
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 
 
 
  
Relative area, % 
2nd cycle 
1st cycle
expansion
compression 
Relative area, % 
Su
rf
ac
e 
pr
es
su
re
, m
N
/m
 
3rd cycle 
Relative area, % 
 
Su
rf
ac
e 
pr
es
su
re
, m
N
/m
 
Su
rf
ac
e 
pr
es
su
re
, m
N
/m
 
0 20 40 60 80 100
0 
20 
40 
60 
80 
 
  
0 20 40 60 80 100
0 
20 
40 
60 
80 
 
  
0 20 40 60 80 100
0 
20 
40 
60 
80 
 
  
 20
        (a)            (b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 
Relative area, % 
expansion 
compression 1st cycleR
A 
in
te
ns
ity
 
50 60 70 80 90 100
-0.006 
-0.005 
-0.004 
-0.003 
-0.002 
-0.001 
  
Relative area, % 
R
A 
in
te
ns
ity
 
50 60 70 80 90 100
-0.006 
-0.005 
-0.004 
-0.003 
-0.002 
-0.001 
  
2nd cycle
3rd cycle
Relative area, % 
R
A 
in
te
ns
ity
 
50 60 70 80 90 100
-0.006 
-0.005 
-0.004 
-0.003 
-0.002 
-0.001 
  
Relative area, % 
expansion 
W
av
en
um
be
r, 
cm
-1
 
compression 
50 60 70 80 90 100 
2919
2920
2921
 
1st cycle 
2nd cycle 
Relative area, % 
W
av
en
um
be
r, 
cm
-1
 
50 60 70 80 90 100 
2919
2920
2921
 
3rd cycle 
Relative area, % 
W
av
en
um
be
r, 
cm
-1
 
50 60 70 80 90 100 
2919
2920
2921
 
